Mirtazapine at 7.5 mg is primarily used as a sleep aid for people with insomnia. This is a lower dose than what’s approved for treating depression, and it’s prescribed specifically because the drug’s sedating effects are strongest at these lower doses. While mirtazapine is FDA-approved only for major depressive disorder (starting at 15 mg), the 7.5 mg dose has become a widely used off-label option for sleep problems.
Why 7.5 mg Instead of a Higher Dose
Mirtazapine has an unusual relationship with dosing. At lower doses, its most prominent effect is blocking histamine receptors in the brain, the same receptors targeted by over-the-counter sleep aids like diphenhydramine. This histamine-blocking activity is what causes drowsiness. At higher doses (30 mg and above), the drug begins activating the brain’s norepinephrine system more strongly, which has an alerting effect that partially counteracts the sedation.
This is why many clinicians prescribe 7.5 mg specifically when the goal is better sleep rather than treating depression. Common references in pharmacology describe mirtazapine as more sedating below 30 mg than at or above that threshold, though a formal dose-response trial confirming this pattern has never been completed. The clinical observation is well-established enough that the 7.5 mg dose has become standard practice for insomnia, even without a dedicated FDA indication for sleep.
How Well It Works for Insomnia
A 2025 randomized trial published in the British Journal of General Practice tested mirtazapine (starting at 7.5 mg, with the option to increase to 15 mg) against placebo in adults with insomnia who hadn’t responded well to non-drug treatments. At six weeks, 52% of people taking mirtazapine showed meaningful improvement compared to just 14% on placebo. Recovery rates followed a similar pattern: 56% versus 14%.
People in the mirtazapine group reported sleeping about one hour longer per night than those on placebo at both the six-week and twelve-week marks. The drug was particularly effective in the first several weeks. By week 12 and beyond, the differences in insomnia severity scores between the mirtazapine and placebo groups were no longer statistically significant, suggesting the benefits may diminish over time or that the placebo group gradually catches up.
One notable finding: the extra sleep didn’t come from fewer nighttime awakenings, as researchers had expected. Instead, people on mirtazapine slept longer overall while also spending more time in bed. So the drug appears to help more with falling asleep and extending total sleep time than with preventing middle-of-the-night wake-ups.
Its Role in Depression Treatment
Mirtazapine’s only FDA-approved use is for major depressive disorder, but the approved starting dose for that condition is 15 mg per day, taken in the evening. Effective antidepressant doses typically range from 15 to 45 mg. At 7.5 mg, the drug doesn’t provide enough of the brain chemical activity needed to treat depression on its own. If your prescriber has you on 7.5 mg for depression, it’s likely a temporary starting point with plans to increase the dose.
Why Some People Start at 7.5 mg
Even when the eventual target is a higher dose for depression, some people begin at 7.5 mg to ease into the medication. This is especially common in older adults. The body clears mirtazapine more slowly with age: elderly men process the drug about 40% slower than younger men, and elderly women about 10% slower. Starting at half the usual dose helps avoid excessive drowsiness or other side effects while the body adjusts.
People with moderate to severe kidney or liver problems also tend to accumulate higher blood levels of the drug, making a lower starting dose a practical choice.
What to Expect When Taking It
Mirtazapine is typically taken once daily in the evening, which aligns with its sedating properties. Most people notice the drowsiness effect within the first one to two hours. The sedation tends to be most noticeable during the first week or two and may lessen somewhat as your body adjusts, though at 7.5 mg the sleepiness usually remains a prominent effect.
The most common side effects at this dose are increased appetite, weight gain, dry mouth, and morning grogginess. The appetite stimulation is significant enough that mirtazapine is sometimes prescribed off-label for people who need to gain weight, such as elderly patients with poor appetite or people recovering from illness. If you’re not looking to gain weight, this side effect is worth monitoring.
Stopping Mirtazapine at 7.5 mg
Withdrawal symptoms from mirtazapine are not as commonly reported as with some other medications in its class, but they can happen, particularly if you stop abruptly. Possible symptoms include nausea, dizziness, insomnia, vivid dreams, anxiety, irritability, and occasional “brain zaps,” which feel like brief electrical sensations in the head. These tend to be mild at the 7.5 mg dose compared to higher doses.
Tapering gradually, typically by reducing the dose by about half every few days, minimizes the chance of withdrawal effects. Even at a low dose, it’s worth planning the stop rather than quitting cold turkey, especially if you’ve been taking it for several months or longer.